Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Intervarsity postponed to 2013
2012-03-08

The annual Intervarsity between the Universities of the Free State and North-West (NWU), which traditionally takes place in the third term, has been postponed to 2013.

The Intervarsity between the UFS and NWU is an illustrious event that has already reached the special milestone of celebrating a 70-year Intervarsity tradition. The UFS/NWU Intervarsity is also known as one of the most reckoned events on the local and national sports and student calendars, and it is widely supported.
 
Representatives from both universities could for a variety of reasons not decide on a date which suited both universities.
 
The respective Intervarsity committees and senior managers of both universities have also taken the interests of the respective university communities and alumni of the institutions into account and have decided to postpone the 70th-year celebration of Intervarsity by a year in order to be able to celebrate the milestone properly.
 
The UFS would have received the NWU in Bloemfontein this year and will therefore host the 70-year celebrations of the event next year as well.
 
Mr Rudi Buys, Dean: Student Affairs at the UFS has expressed his gratitude for the fact that both universities are committed to a special celebration of the Intervarsity tradition in 2013.
 
“The celebration of the 70th Intervarsity between the two institutions will be an important milestone to commemorate decades of friendship, collaboration and healthy competition. Therefore we welcome this opportunity to plan a bigger and better programme for 2013,” he said.
 
The UFS-NWU 70-YEAR Intervarsity firstly aims to establish the programme as a proud example for both universities, where students and staff can pit their strengths against one another in a healthy manner.
 
The aim is to extend Intervarsity to various sections of the respective university communities to enable more students to participate. For instance, more sports codes will be added to the traditional competition on the rugby, soccer, netball and hockey fields, whilst various events focusing on arts and culture, i.e. choral singing and debating competitions, as well as dialogue between student leaders, will take place as part of the programme. All campuses of the two universities will participate in the programmes.
 
Students are even investigating the possibility of electronic competitions such as on-line games as part of the Intervarsity
 
During the Intervarsity last year, several new possibilities were already tested to ensure that the 70th anniversary would be a huge success.
 
The Central Intervarsity Committee of the UFS has decided to replace the Intervarsity 2012 programme with an INTRA-varsity programme between its respective campuses. For this occasion, various sports, arts and culture, and leadership events between the Bloemfontein and Qwaqwa Campuses are planned, and the Central University of Technology might be invited as well to participate as guests in some programmes.

Media Release
8 March 2012
Issued by: Lacea Loader
Director: Strategic Communication
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: news@ufs.ac.za


 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept